ISIS-14803 | Interleukin Related interleukin-related.com

Product Name :
ISIS-14803

Search keywords :
ISIS 14803

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Protein biosynthesis inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Hepatitis C, Chronic

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATG3 Antibody
Phospho-PKA RII alpha (Ser99) Antibody
SIRT2 Antibody: SIRT2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to SIRT2. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts